Tuesday, 21 October 2014
Last updated 2 hours ago
Jan 13 2006 | 8:59pm ET
The Securities and Exchange Commission is considering taking action against hedge fund Perry Capital in relation to the firm's trading shares of pharmaceuticals company Mylan Laboratories Inc.
According to a statement released by Perry Capital on Wednesday, a Wells notice was recently sent to the firm's founder, Richard Perry, who was formerly with Goldman Sachs.
Carl Berg, a portfolio manager at Perry, also received a letter from the SEC, saying that regulators are recommending legal action against the firm. The SEC believes that Perry Capital's trading of Mylan shares may have violated certain provisions of federal securities laws, including Sections 10(b) and 13(d) of the Securities Exchange Act of 1934, Perry said in its statement.
The hedge fund, which has $10 billion is assets under management, claims that is has done nothing wrong and plans to respond to regulators.
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Sep 30 2014 | 9:29am ET
The crisp Autumnal days of October are upon us, and so are a few of the hedge fund industry’s favorite charitable events. If you have never been to Rocktoberfest, well, you are missing out. And for a quieter evening of sipping and socializing, stop by HFC’s Wine Soiree. Read more…
Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...